{{Rsnum
|rsid=1927457
|Gene=SVIL
|Chromosome=10
|position=30008663
|Orientation=plus
|GMAF=0.3852
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 10.6 | 35.4 | 54.0
| HCB | 17.6 | 47.8 | 34.6
| JPT | 23.0 | 48.7 | 28.3
| YRI | 17.2 | 49.0 | 33.8
| ASW | 22.8 | 52.6 | 24.6
| CHB | 17.6 | 47.8 | 34.6
| CHD | 23.9 | 55.0 | 21.1
| GIH | 16.8 | 56.4 | 26.7
| LWK | 23.9 | 45.0 | 31.2
| MEX | 8.6 | 41.4 | 50.0
| MKK | 21.2 | 52.6 | 26.3
| TSI | 9.8 | 52.0 | 38.2
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19010793
|Trait=Normalized brain volume
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000008
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs1927457
|Name_s=
|Gene_s=SVIL
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 753 cases, 883 controls; Replication Sample Size: NR); (Region: 10p11.23; Reported Gene(s): SVIL; Risk Allele: rs1927457-?); (p-value= 0.000008).This variant is associated with Normalized brain volume.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740738
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1927457
|overall_frequency_n=45
|overall_frequency_d=128
|overall_frequency=0.351562
|n_genomes=31
|n_genomes_annotated=0
|n_haplomes=36
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}